TAGOVAMERAN EXPRESSED SARS-COV-2 SPIKE GLYCOPROTEIN ANTIGEN

UNII:	37WJ4R2YAU
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TAGOVAMERAN EXPRESSED SARS-COV-2 SPIKE GLYCOPROTEIN ANTIGEN
GSRS Full Record:	37WJ4R2YAU i

Tagovameran expressed SARS-CoV-2 spike glycoprotein antigen
Tagovameran expressed SARS-CoV-2 spike glycoprotein, S1 and S2 domains, with prefusion-stabilizing mutations (K981P and V982P), furin-cleavage-inactivating mutations (R677G, R678S, and R680S), and mutations present in the spike glycoproteins of the Omicron BA.4/5 variants, for which the protein sequences are identical

Inxight Drugs
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TAGOVAMERAN EXPRESSED SARS-COV-2 SPIKE GLYCOPROTEIN ANTIGEN

Synonyms and Mappings

Resources